Vitamin E claim
This article was originally published in The Tan Sheet
Proposed vitamin E/heart disease dietary supplement health claim rejected by FDA Feb. 9. Plaintiffs in Whitaker v. Shalala lawsuit pending in D.C. federal court are now expected to restart the litigation, which has been stayed pending agency's reexamination of the claim
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC